DXCM - Company ID 0001093557
The table below shows DEXCOM INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $917.70M | $606.10M | $566.30M | $642.30M | $1.05B | $817.60M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.22B | $1.01B | $973.90M | $713.30M | $514.30M | $428.50M |
| Inventory | $629.10M | $542.60M | $559.60M | $306.70M | $357.30M | $234.70M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.03B |
| $4.30B |
| $4.43B |
| $3.67B |
| $3.68B |
| $3.42B |
| Property, plant & equipment | - | - | - | - | $801.80M | $515.30M |
| Goodwill | $24.20M | $22.80M | $25.20M | $25.70M | $26.50M | $19.30M |
| Total assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.86B | $4.29B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $720.80M | $614.10M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.61B | $2.46B |
| Retained earnings | $2.43B | $1.60B | $1.02B | $479.90M | -$47.40M | -$202.10M |
| Total equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.25B | - |